Recursion Pharmaceuticals Inc Net Asset Quality Index
Recursion Pharmaceuticals Inc net asset quality index. Recursion Pharmaceuticals Inc (RXRX) has a Net Asset Quality Index of 75.5% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.21 Billion minus total liabilities of $297.67 Million yields net assets of $915.00 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Recursion Pharmaceuticals Inc shareholders equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Recursion Pharmaceuticals Inc (2019–2025)
Net asset quality index of Recursion Pharmaceuticals Inc from 2019 to 2025. This chart shows how Recursion Pharmaceuticals Inc's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of June 2026, the index stands at 75.5%, representing net assets of $915.00 Million against total assets of $1.21 Billion USD. Check Recursion Pharmaceuticals Inc (RXRX) strategic asset index to assess the company's strategic physical and investment asset allocation.
Recursion Pharmaceuticals Inc Net Asset Quality Index by Year (2019–2025)
Recursion Pharmaceuticals Inc net asset quality index by year from 2019 to 2025. The table below presents the year-by-year Net Asset Quality Index for Recursion Pharmaceuticals Inc from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see RXRX market cap overview.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 76.7% | $1.13 Billion | $1.47 Billion | $343.26 Million | ▲ +5.3 pp |
| 2024 | 71.4% | $1.03 Billion | $1.45 Billion | $413.82 Million | ▲ +0.5 pp |
| 2023 | 70.9% | $463.44 Million | $653.70 Million | $190.26 Million | ▲ +1.6 pp |
| 2022 | 69.3% | $485.81 Million | $701.29 Million | $215.48 Million | ▼ -19.7 pp |
| 2021 | 89.0% | $542.94 Million | $610.35 Million | $67.41 Million | ▲ +158.0 pp |
| 2020 | -69.1% | $-206.29 Million | $298.58 Million | $504.87 Million | ▲ +53.4 pp |
| 2019 | -122.5% | $-124.27 Million | $101.43 Million | $225.70 Million | — |